Intuitive Surgical (NASDAQ:ISRG) Posts Quarterly Earnings Results, Beats Estimates By $1.02 EPS

Share on StockTwits

Intuitive Surgical (NASDAQ:ISRG) announced its earnings results on Thursday. The medical equipment provider reported $3.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.23 by $1.02, RTT News reports. Intuitive Surgical had a return on equity of 17.33% and a net margin of 29.78%. The firm had revenue of $1.10 billion during the quarter, compared to analyst estimates of $1.03 billion. During the same quarter in the prior year, the company earned $2.76 EPS. The business’s revenue was up 20.9% compared to the same quarter last year.

Intuitive Surgical stock opened at $536.63 on Friday. The stock has a market cap of $60.44 billion, a P/E ratio of 56.55, a P/E/G ratio of 4.57 and a beta of 1.08. The stock has a 50 day moving average of $512.77. Intuitive Surgical has a twelve month low of $430.24 and a twelve month high of $589.32.

Several brokerages have recently issued reports on ISRG. Zacks Investment Research lowered GenMark Diagnostics from a “hold” rating to a “sell” rating in a research report on Wednesday, April 24th. ValuEngine upgraded Valmont Industries from a “sell” rating to a “hold” rating in a research note on Friday, July 12th. Canaccord Genuity restated a “buy” rating and issued a $610.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a research note on Friday. Cantor Fitzgerald set a $620.00 price target on Intuitive Surgical and gave the stock a “buy” rating in a research note on Thursday, April 4th. Finally, Citigroup upgraded China Petroleum & Chemical from a “neutral” rating to a “buy” rating in a research note on Tuesday, May 14th. Three investment analysts have rated the stock with a sell rating, three have assigned a hold rating and twelve have issued a buy rating to the company. Intuitive Surgical currently has a consensus rating of “Buy” and an average target price of $580.27.

In related news, COO Salvatore Brogna sold 1,172 shares of the company’s stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $500.60, for a total value of $586,703.20. Following the sale, the chief operating officer now owns 5,933 shares in the company, valued at approximately $2,970,059.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Jamie Samath sold 130 shares of the company’s stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $500.60, for a total value of $65,078.00. Following the completion of the sale, the vice president now owns 219 shares in the company, valued at approximately $109,631.40. The disclosure for this sale can be found here. Insiders sold a total of 27,621 shares of company stock worth $13,828,454 in the last 90 days. 1.70% of the stock is currently owned by company insiders.

A number of large investors have recently bought and sold shares of the business. Icon Wealth Partners LLC purchased a new position in Intuitive Surgical in the first quarter worth about $26,000. Stone House Investment Management LLC purchased a new position in Intuitive Surgical in the first quarter worth $31,000. Advisory Alpha LLC purchased a new stake in shares of Intuitive Surgical during the first quarter valued at $32,000. Ellis Investment Partners LLC purchased a new stake in shares of Intuitive Surgical during the first quarter valued at $34,000. Finally, Liberty Wealth Management LLC purchased a new stake in Intuitive Surgical in the fourth quarter valued at $37,000. 85.56% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Featured Story: What does a dividend yield signify to investors?

Earnings History for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Brokerages Anticipate Inogen Inc  Will Announce Quarterly Sales of $91.38 Million
Brokerages Anticipate Inogen Inc Will Announce Quarterly Sales of $91.38 Million
$0.74 EPS Expected for Clean Harbors Inc  This Quarter
$0.74 EPS Expected for Clean Harbors Inc This Quarter
Medpace Holdings Inc  Receives Consensus Recommendation of “Buy” from Analysts
Medpace Holdings Inc Receives Consensus Recommendation of “Buy” from Analysts
$278.76 Million in Sales Expected for BJ’s Restaurants, Inc.  This Quarter
$278.76 Million in Sales Expected for BJ’s Restaurants, Inc. This Quarter
Analysts Expect Washington Federal Inc.  Will Post Earnings of $0.66 Per Share
Analysts Expect Washington Federal Inc. Will Post Earnings of $0.66 Per Share
Elevate Credit Inc  Receives Average Rating of “Hold” from Analysts
Elevate Credit Inc Receives Average Rating of “Hold” from Analysts


 
© 2006-2019 Zolmax.